[1] Jose S, Delpech V, Howarth A, et al. A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study. Lancet HIV, 2018; 5, e301−8. doi:  10.1016/S2352-3018(18)30048-1
[2] Liu PT, Tang ZZ, Lan GH, et al. Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program. Sci Rep, 2018; 8, 3431. doi:  10.1038/s41598-018-21791-2
[3] Pan SW, Shen ZY, Xing H, et al. High baseline CD4 counts and antiretroviral therapy cessation. Clin Infect Dis, 2018; 67, 644. doi:  10.1093/cid/ciy131
[4] Mekonnen GB, Addis SA. Factors affecting adherence to co-trimoxazole preventive therapy in HIV/AIDS patients attending an antiretroviral therapy clinic in Ethiopia university hospital: a cross-sectional study. Patient Prefer Adherence, 2020; 14, 881−90. doi:  10.2147/PPA.S252805
[5] Ku SWW, Jiamsakul A, Joshi K, et al. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc, 2019; 22, e25264. doi:  10.1002/jia2.25264
[6] Polyak CS, Yuhas K, Singa B, et al. Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-Infected adults in Kenya: a randomized non-inferiority trial. PLoS Med, 2016; 13, e1001934. doi:  10.1371/journal.pmed.1001934
[7] Jiang JJ, Qin FX, Meng SR, et al. Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study. Emerg Microbes Infect, 2019; 8, 367−76. doi:  10.1080/22221751.2019.1588078
[8] Orishaba P, Kalyango JN, Byakika-Kibwika P, et al. Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda. PLoS One, 2020; 15, e0240838. doi:  10.1371/journal.pone.0240838
[9] Mecha JO, Kubo EN, Nganga LW, et al. Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004-2015 retrospective cohort study. HIV/AIDS-Res Palliat, 2018; 10, 103−14. doi:  10.2147/HIV.S153185